The Effect of LY2409021 on Blood Pressure and Pulse Rate, as Assessed by Ambulatory Blood Pressure Monitoring, in Subjects With Type 2 Diabetes Mellitus
Phase of Trial: Phase II
Latest Information Update: 25 Jul 2018
Price : $35 *
At a glance
- Drugs Adomeglivant (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Eli Lilly
- 31 Aug 2018 Biomarkers information updated
- 09 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Sep 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.